Integra Lifesciences Priced $450M Senior Secured Notes at 9.500%

By Greg Peters • Sunday, October 11 10:53 • Permanent Link

Integra Lifesciences Holdings priced $450 million of senior secured notes due 2033 at 9.500%, setting up a refinancing of its existing credit facilities.

The company said the notes are expected to close on or about Oct. 19, 2026. Integra plans to pair the bond proceeds with borrowings from a new credit facility to refinance its current debt and cover related fees and expenses.

The new notes will sit as general senior secured obligations of Integra and will be guaranteed by the company’s wholly owned domestic subsidiaries that already back its senior secured credit facilities.

The transaction marks a broader refinancing move for the Princeton, N.J.-based medical technology company, which said the offering is part of a larger capital structure reset. As a result of these announcements, the company's shares have moved 3.15% on the market, and are now trading at a price of $13.41. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.